CRISPR Therapeutics is a leading brand in the field of gene editing, with a mission to transform the lives of patients facing serious diseases. They offer a range of gene-based medicines, using the revolutionary CRISPR/Cas9 technology, to target and treat a variety of conditions. Their pipeline includes programs focused on hemoglobinopathies, such as β-thalassemia and sickle cell disease, where they aim to use gene-edited hematopoietic stem cells to provide effective treatment.

They are also working on immuno-oncology, developing the next generation of cell therapies for cancer through gene editing. In addition, they are exploring the potential of in vivo editing, treating genetically-defined diseases by editing cells inside the body. CRISPR Therapeutics is at the forefront of regenerative medicine, broadening the applications of stem cells through gene editing.

With a track record of delivering results, they are actively engaged in clinical research and provide expanded access to investigational medicines. Join their team of talented individuals and contribute to their groundbreaking work in revolutionizing the future of medicine